Viridian Therapeutics Overview
Viridian Therapeutics Target Price
Analysts' 12-month price predictions for VRDN.
Get informed when a big investor buys or sells
+ FollowShare Price
$16.35
Average Target Price
$34.86
113.2% upside
113.2% upside7 analysts in the last 4 months
High: $45 | Low: $26
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-15 | Evercore ISI | $26 | 59% upside |  |
| 2026-05-13 | Stifel Nicolaus | $39 | 138.5% upside | |
| 2026-05-06 | RBC Capital | $34 | 108% upside | |
| 2026-04-21 | Truist Financial | $33 | 101.8% upside | |
| 2026-04-08 | Truist Financial | $36 | 120.2% upside | |
| 2026-04-08 | WedbushLaura Chico | $31 | 89.6% upside | |
| 2026-02-26 | JefferiesKelly Shi | $45 | 175.2% upside | |
| 2026-01-28 | Evercore ISIGavin Clark-Gartner | $45 | 175.2% upside | |
| 2026-01-20 | Evercore ISIGavin Clark-Gartner | $44 | 169.1% upside | |
| 2026-01-07 | UBS | $50 | 205.8% upside | |
| 2025-12-03 | William Blair | $47 | 187.5% upside | |
| 2025-11-24 | Truist Financial | $41 | 150.8% upside | |
| 2025-11-06 | RBC Capital | $45 | 175.2% upside | |
| 2025-11-06 | Goldman Sachs | $40 | 144.6% upside | |
| 2025-11-05 | Stifel NicolausAlex Thompson | $48 | 193.6% upside | |
| 2025-10-21 | Oppenheimer | $36 | 120.2% upside | |
| 2025-10-21 | H.C. WainwrightDouglas Tsao | $34 | 108% upside | |
| 2024-11-12 | Stifel NicolausAlex Thompson | $20.5 | 25.4% upside | |
| 2024-09-13 | RBC CapitalGregory Renza | $22 | 34.6% upside | |
| 2024-09-11 | NeedhamSerge Belanger | $19 | 16.2% upside | |
| 2024-09-11 | B.Riley FinancialKalpit Patel | $22 | 34.6% upside | |
| 2024-09-10 | Stifel NicolausAlex Thompson | $20 | 22.3% upside | |
| 2024-09-10 | BTIGJulian Harrison | $28 | 71.3% upside | |
| 2024-08-14 | Goldman SachsRichard Law | $25 | 52.9% upside | |
| 2024-06-11 | RBC CapitalGregory Renza | $17.5 | 7% upside | |
| 2024-06-11 | BTIGJulian Harrison | $23 | 40.7% upside | |
| 2024-06-10 | Wolfe ResearchAndy Chen | $14.5 |  11.3% downside | |
| 2024-06-06 | Goldman SachsRichard Law | $11.5 | 29.7% downside | |
| 2024-05-09 | OppenheimerLeland Gershell | $15.5 | 5.2% downside | |
| 2024-05-09 | H.C. WainwrightDouglas Tsao | $13.5 | 17.4% downside | |
| 2024-05-09 | B.Riley FinancialKalpit Patel | $20 | 22.3% upside | |
| 2023-01-09 | Leerink Partners | $45 | 175.2% upside | |
| 2022-12-19 | Needham | $45 | 175.2% upside | |
| 2022-12-16 | Credit Suisse | $25.5 | 56% upside | |
| 2022-12-01 | H.C. Wainwright | $35 | 114.1% upside | |
| 2022-11-15 | JMP Securities | $23 | 40.7% upside | |